These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 35123522)

  • 1. Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy.
    Zhao R; Fu J; Zhu L; Chen Y; Liu B
    J Hematol Oncol; 2022 Feb; 15(1):14. PubMed ID: 35123522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias.
    Nguyen LD; Chau RK; Krichevsky AM
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
    Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
    Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer.
    Wang J; Song YX; Ma B; Wang JJ; Sun JX; Chen XW; Zhao JH; Yang YC; Wang ZN
    Int J Mol Sci; 2015 Aug; 16(8):19886-919. PubMed ID: 26307974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
    Disney MD; Angelbello AJ
    Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and other non-coding RNAs as targets for anticancer drug development.
    Ling H; Fabbri M; Calin GA
    Nat Rev Drug Discov; 2013 Nov; 12(11):847-65. PubMed ID: 24172333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NoncoRNA: a database of experimentally supported non-coding RNAs and drug targets in cancer.
    Li L; Wu P; Wang Z; Meng X; Zha C; Li Z; Qi T; Zhang Y; Han B; Li S; Jiang C; Zhao Z; Cai J
    J Hematol Oncol; 2020 Feb; 13(1):15. PubMed ID: 32111231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncoding RNAs in cancer therapy resistance and targeted drug development.
    Wang WT; Han C; Sun YM; Chen TQ; Chen YQ
    J Hematol Oncol; 2019 Jun; 12(1):55. PubMed ID: 31174564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
    Grillone K; Riillo C; Scionti F; Rocca R; Tradigo G; Guzzi PH; Alcaro S; Di Martino MT; Tagliaferri P; Tassone P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):117. PubMed ID: 32563270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs: Emerging from the discovery to therapeutic applications.
    Baptista B; Riscado M; Queiroz JA; Pichon C; Sousa F
    Biochem Pharmacol; 2021 Jul; 189():114469. PubMed ID: 33577888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs: the new central dogma of cancer biology.
    Saw PE; Xu X; Chen J; Song EW
    Sci China Life Sci; 2021 Jan; 64(1):22-50. PubMed ID: 32930921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
    Di Giorgio A; Tran TP; Duca M
    Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance.
    Wang H; Fleishman JS; Cheng S; Wang W; Wu F; Wang Y; Wang Y
    Mol Cancer; 2024 Aug; 23(1):177. PubMed ID: 39192329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer using fragment based drug discovery.
    Turnbull AP; Boyd SM
    Anticancer Agents Med Chem; 2012 Jan; 12(1):40-8. PubMed ID: 21707503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure based approaches for targeting non-coding RNAs with small molecules.
    Shortridge MD; Varani G
    Curr Opin Struct Biol; 2015 Feb; 30():79-88. PubMed ID: 25687935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategic and Innovative Roles of lncRNAs Regulated by Naturally-derived Small Molecules in Cancer Therapy.
    Alkan AH; Ensoy M; Cansaran-Duman D
    Curr Med Chem; 2024; 31(40):6672-6691. PubMed ID: 37921177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA in thyroid cancer - Functions and mechanisms.
    Cao J; Zhang M; Zhang L; Lou J; Zhou F; Fang M
    Cancer Lett; 2021 Jan; 496():117-126. PubMed ID: 32949678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNAs in human disease.
    Esteller M
    Nat Rev Genet; 2011 Nov; 12(12):861-74. PubMed ID: 22094949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.